- Home
- BTAI vs AEHL Comparison
BTAI vs AEHL Comparison
Compare BTAI & AEHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- AEHL
- Stock Information
- Founded
- BTAI 2017
- AEHL 1993
- Country
- BTAI United States
- AEHL China
- Employees
- BTAI N/A
- AEHL N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- AEHL Building Materials
- Sector
- BTAI Health Care
- AEHL Industrials
- Exchange
- BTAI Nasdaq
- AEHL Nasdaq
- Market Cap
- BTAI 8.3M
- AEHL 8.5M
- IPO Year
- BTAI 2018
- AEHL 2007
- Fundamental
- Price
- BTAI $1.93
- AEHL $3.00
- Analyst Decision
- BTAI Buy
- AEHL
- Analyst Count
- BTAI 5
- AEHL 0
- Target Price
- BTAI $34.60
- AEHL N/A
- AVG Volume (30 Days)
- BTAI 289.2K
- AEHL 102.7K
- Earning Date
- BTAI 08-05-2025
- AEHL 05-01-2025
- Dividend Yield
- BTAI N/A
- AEHL N/A
- EPS Growth
- BTAI N/A
- AEHL N/A
- EPS
- BTAI N/A
- AEHL N/A
- Revenue
- BTAI $1,852,000.00
- AEHL $98,773,000.00
- Revenue This Year
- BTAI $5.03
- AEHL N/A
- Revenue Next Year
- BTAI $291.01
- AEHL N/A
- P/E Ratio
- BTAI N/A
- AEHL N/A
- Revenue Growth
- BTAI 5.47
- AEHL 36.99
- 52 Week Low
- BTAI $1.17
- AEHL $1.79
- 52 Week High
- BTAI $21.92
- AEHL $256.40
- Technical
- Relative Strength Index (RSI)
- BTAI 56.97
- AEHL 63.56
- Support Level
- BTAI $1.69
- AEHL $2.33
- Resistance Level
- BTAI $2.08
- AEHL $3.25
- Average True Range (ATR)
- BTAI 0.20
- AEHL 0.26
- MACD
- BTAI 0.02
- AEHL 0.06
- Stochastic Oscillator
- BTAI 61.84
- AEHL 72.83
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.